This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Delivered as a Hybrid Event
February 27 - March 2, 2023San Diego Convention Center

Ashton Lavoie
Head of Downstream Process Development at BridgeBio Gene Therapy (BridgeBio Pharma)

Profile

Ashton is the Head of Downstream Process Development at BridgeBio Gene Therapy. She has been with BridgeBio for three years, with heavy focus on implementation of strategies and technologies to improve AAV purification processes. She earned her bachelors in Chemical Engineering at Northeastern University, and her masters and Ph.D. in Chemical Engineering at North Carolina State University. She has worked in biomanufacturing for 13 years with academic and industrial experience spanning upstream and downstream process development, technology transfer, and primary cell isolation.

Agenda Sessions

  • AEX Enrichment of AAV5 Full Capsids with Dual Salt Elution Gradients

    4:00pm

Speakers at this event